Artisan Pharma’s Lead Product, ART-123, Approved In Japan
Artisan Pharma, Inc. announced that the Japanese Pharmaceutical and Medical Device Agency approved Artisan’s lead drug, ART-123 (human, soluble, recombinant thrombomodulin), on January 25, 2008 for the treatment of disseminated intravascular coagulation (”DIC”) in Japan. The approval of ART-123, which was received by Artisan’s partner and licensor of ART-123, Asahi Kasei Pharma Corporation (”AKP”), further establishes AKP as a leader in biologic pharmaceutical product development.
More: continued here